The paper analyzes the development of the prescription and consumption of hypolipidemic agents from 2000 to 2004. The principal database consisted of dispensed medical prescriptions and the consumption of hypolipidemic agents was expressed in DDD, DID, financially, and in the form of proportional representation. In the year 2004 hypolipidemic agents represented 11.8% of the total costs for medicaments (statins, 8.9%, and 75.6%, respectively, fibrates, 2.9% and 24.4%, respectively), in DDD statins, 69.0%, fibrates, 31.0%. The most frequently prescribed preparation was simvastatin, 57.8% DDD and 60.3% in financial units.